But no plain bowtie2-build (the -l is for 64-bit indexes but they are not supported by TopHat as yet)?
-
-
No, I have a plain bowtie2-build as well.Comment
-
I am stumped.
Give a real sample a try to see if that works.Comment
-
Damn =P I'll do that and see if it works. Thanks for all your help, regardless!Comment
-
Downgrading to Bowtie 2.2.2 did the trick! Must have been a bug or something in 2.2.3...Comment
-
I was using Bowtie 2.2.1. Won't upgrade to 2.2.3.Comment
-
Error in testing the installation of Tophat
I'm a brand new person in RNA-Seq and a beginner in bioinformatics as well. So my apologies if my question is naïve or it has been posted already. Recently I installed Tophat v2.0.12, with Bowtie, SAMtools and Boost libraries, in Ubuntu 12.04 lts 32-bits. However when I tried to test the installation
tophat -r 20 test_ref reads_1.fq reads_2.fq
I got this error:
[2014-07-04 10:52:25] Beginning TopHat run (v2.0.12)
-----------------------------------------------
[2014-07-04 10:52:25] Checking for Bowtie
Bowtie 2 not found, checking for older version..
Error: TopHat requires Bowtie 0.12.9 or later
It seems to me there is a problem with the version of bowtie I have installed, perhaps to old? If you could please give some clue about how to solve this problem?
Thanks in advancedComment
-
If you only have bowtie (v.1.x) installed then you may need to add the following optionOriginally posted by lamaga View Post
It may be better to install bowtie2 (http://sourceforge.net/projects/bowt...les/bowtie2/)?Code:$ tophat --bowtie1 -r 20 test_ref reads_1.fq reads_2.fq
Or it may be a simple fix of adjusting your $PATH so bowtie directories are included there.Last edited by GenoMax; 07-06-2014, 06:21 AM.Comment
-
You need the newest version of tophat
TopHat 2.0.12 release 6/24/2014
Version 2.0.12 is a maintenance release with the following simple fix:
This version is compatible with Bowtie2 v2.2.3.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment